arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

download Export Data

VERTEX PHARMACEUTICALS INC / MA

VRTX

$496.02 ▲ +11.75 (+2.43%) at close

19 Visible periods

29 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Excellent

Bullish

auto_awesome

Analytical Summary

VERTEX PHARMACEUTICALS INC / MA shows strong fundamentals with top-quartile Return on Common Equity (%) and Profit Margin (%). The company's metrics support a bullish outlook for growth-oriented investors.

Market Cap $126.8B

Dividend Yield —

Revenue Growth 8.9% ↘

Op. Margin 34.8% ↗

ROIC 19.0% ↗

FCF / Share $12.49 ↗

Trailing P/E 32.1x

Price / Book 6.8x

FCF Yield 2.5%

Debt / Equity —

info Valuation on last close. End-of-day price, Aug 7, 2026.

19-Year Financial Trajectory

Annual

Metric Value Trend Year over Year Percentile

Revenue Total top-line sales

$12.00B

↑ +8.9% —

Net Income Profit after all expenses

$3.95B

↑ +838.1% —

Operating Margin Operating profit as % of sales

34.8%

↑ +1745.4% 90th

FCF / Share Free cash flow per share

$12.49

↑ +507.6% —

trending_up

Bullish Indicators

Operating Margin (%)Operating Margin (%) is in the top quartile
Profit Margin (%)Profit Margin (%) is in the top quartile
Return on Common Equity (%)Return on Common Equity (%) is in the top quartile

warning

Bearish Risks

No bearish risks detected.

Health Breakdown

Profitability ↓

Returns ↓

Financial Health ↑

Cash Quality ↓

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 7 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗	FY 2009 Dec 31, 2009 10-K ↗	FY 2008 Dec 31, 2008 10-K ↗	FY 2007 Dec 31, 2007 10-K ↗
Revenue Growth YoY (%)	8.9% Fair ↓ Fair Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+11%)	11.7% Good ↓ Good Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+46%)	10.5% Good ↓ Good Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+31%)	17.9% Good ↓ Good Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+124%)	22.1% Excellent ↓ Excellent Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+176%)	49.1% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+513%)	36.6% Excellent ↓ Excellent Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+357%)	22.5% Excellent ↓ Excellent Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+181%)	46.2% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+478%)	64.9% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+711%)	77.9% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+873%)	-52.1% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-751%)	-20.6% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-358%)	8.3% Fair ↓ Fair Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: At sector avg	883.9% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+10949%)	40.7% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+409%)	-41.9% Weak Weak Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-624%)	—	—
EPS Growth YoY (%)	N/M	N/M	8.3% Fair ↓ Fair Declining Year-over-year change in earnings per share Optimal: > 10%	42.7% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	-12.9% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	127.9% Excellent ↓ Excellent Declining Year-over-year change in earnings per share Optimal: > 10%	-44.4% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	677.4% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	N/M	80.1% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	26.4% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	-58.6% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	-296.0% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	N/M	N/M	-1.6% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	-13.5% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	—	—
Net Income Growth YoY (%)	N/M	N/M	9.0% Fair ↓ Fair Declining Year-over-year change in net income	41.8% Excellent ↑ Excellent Improving Year-over-year change in net income	-13.6% Weak ↓ Weak Declining Year-over-year change in net income	130.4% Excellent ↓ Excellent Declining Year-over-year change in net income	-43.9% Weak ↓ Weak Declining Year-over-year change in net income	695.8% Excellent ↑ Excellent Improving Year-over-year change in net income	N/M	79.9% Excellent ↑ Excellent Improving Year-over-year change in net income	24.7% Good ↑ Good Improving Year-over-year change in net income	-66.0% Weak Weak Year-over-year change in net income	-315.8% Weak Weak Year-over-year change in net income	N/M	N/M	-17.5% Weak Weak Year-over-year change in net income	-39.6% Weak Weak Year-over-year change in net income	—	—
FCF Growth YoY (%)	N/M	N/M	-15.5% Weak ↓ Weak Declining Year-over-year change in free cash flow	64.0% Excellent ↑ Excellent Improving Year-over-year change in free cash flow	-18.9% Weak ↓ Weak Declining Year-over-year change in free cash flow	98.0% Excellent ↓ Excellent Declining Year-over-year change in free cash flow	26.0% Excellent ↓ Excellent Declining Year-over-year change in free cash flow	54.2% Excellent ↓ Excellent Declining Year-over-year change in free cash flow	308.3% Excellent ↑ Excellent Improving Year-over-year change in free cash flow	N/M	29.0% Excellent ↑ Excellent Improving Year-over-year change in free cash flow	-423.9% Weak Weak Year-over-year change in free cash flow	N/M	74.2% Excellent Excellent Year-over-year change in free cash flow	—	—	-41.5% Weak Weak Year-over-year change in free cash flow	—	—
Revenue CAGR 3Y (%)	10.4% Good ↓ Good Declining Compound annual revenue growth over 3 years	13.3% Good ↓ Good Declining Compound annual revenue growth over 3 years	16.7% Excellent ↓ Excellent Declining Compound annual revenue growth over 3 years	29.0% Excellent ↓ Excellent Declining Compound annual revenue growth over 3 years	35.5% Excellent ↓ Excellent Declining Compound annual revenue growth over 3 years	35.6% Excellent ↓ Excellent Declining Compound annual revenue growth over 3 years	34.7% Excellent ↓ Excellent Declining Compound annual revenue growth over 3 years	43.5% Excellent ↑ Excellent Improving Compound annual revenue growth over 3 years	62.5% Excellent ↑ Excellent Improving Compound annual revenue growth over 3 years	12.0% Good ↓ Good Declining Compound annual revenue growth over 3 years	-12.2% Weak ↓ Weak Declining Compound annual revenue growth over 3 years	-25.6% Weak ↓ Weak Declining Compound annual revenue growth over 3 years	103.7% Excellent ↓ Excellent Declining Compound annual revenue growth over 3 years	146.6% Excellent Excellent Compound annual revenue growth over 3 years	100.3% Excellent Excellent Compound annual revenue growth over 3 years	—	—	—	—
Revenue CAGR 5Y (%)	14.1% Excellent ↓ Excellent Declining Compound annual revenue growth over 5 years	21.5% Excellent ↓ Excellent Declining Compound annual revenue growth over 5 years	26.5% Excellent ↓ Excellent Declining Compound annual revenue growth over 5 years	29.1% Excellent ↓ Excellent Declining Compound annual revenue growth over 5 years	34.8% Excellent ↓ Excellent Declining Compound annual revenue growth over 5 years	43.2% Excellent ↑ Excellent Improving Compound annual revenue growth over 5 years	48.3% Excellent ↑ Excellent Improving Compound annual revenue growth over 5 years	20.3% Excellent → Excellent Stable Compound annual revenue growth over 5 years	10.3% Good ↓ Good Declining Compound annual revenue growth over 5 years	3.8% Caution ↓ Caution Declining Compound annual revenue growth over 5 years	48.4% Excellent ↑ Excellent Improving Compound annual revenue growth over 5 years	41.6% Excellent Excellent Compound annual revenue growth over 5 years	47.2% Excellent Excellent Compound annual revenue growth over 5 years	—	—	—	—	—	—
EPS CAGR 3Y (%)	6.0% Fair ↓ Fair Declining Compound annual EPS growth over 3 years	—	10.4% Good ↓ Good Declining Compound annual EPS growth over 3 years	41.5% Excellent ↓ Excellent Declining Compound annual EPS growth over 3 years	3.3% Caution Caution Compound annual EPS growth over 3 years	114.4% Excellent Excellent Compound annual EPS growth over 3 years	—	—	—	—	—	—	—	—	—	—	—	—	—

💰 Are margins durable? 5 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗	FY 2009 Dec 31, 2009 10-K ↗	FY 2008 Dec 31, 2008 10-K ↗	FY 2007 Dec 31, 2007 10-K ↗
Operating Margin (%) (%)	34.8% Excellent ↑ Excellent Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+132%)	-2.1% Weak ↓ Weak Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-114%)	38.8% Excellent ↓ Excellent Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+159%)	48.2% Excellent ↑ Excellent Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+222%)	36.7% Excellent ↑ Excellent Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+145%)	46.0% Excellent ↑ Excellent Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+207%)	28.8% Excellent ↑ Excellent Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+92%)	20.8% Good ↑ Good Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+39%)	5.0% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-67%)	0.6% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-96%)	-45.2% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-402%)	-119.3% Weak ↓ Weak Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-895%)	-50.3% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-436%)	0.2% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-99%)	8.1% Caution ↑ Caution Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-46%)	-485.5% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-3337%)	—	-263.6% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1858%)	—
Effective Tax Rate (%) (%)	14.9% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	315.5% Weak ↑ Weak Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	17.4% Good ↑ Good Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	21.5% Fair ↑ Fair Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	14.2% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	13.0% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	—	—	—	—	—	—	—	—	—	—	—	—	—
Profit Margin (%) (%)	32.9% Excellent ↑ Excellent Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+174%)	-4.9% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-141%)	36.7% Excellent → Excellent Stable Net income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+206%)	37.2% Excellent ↑ Excellent Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+210%)	30.9% Excellent ↓ Excellent Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+158%)	43.7% Excellent ↑ Excellent Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+264%)	28.3% Excellent ↑ Excellent Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+136%)	68.8% Excellent ↑ Excellent Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+473%)	10.6% Fair ↑ Fair Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-12%)	-6.6% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-155%)	-53.9% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-549%)	-127.2% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1160%)	-36.7% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-406%)	-7.0% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-158%)	2.1% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-83%)	—	—	-262.0% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2283%)	—
FCF Margin (%) (%)	26.6% Excellent ↑ Excellent Improving Free cash flow as a percentage of revenue Optimal: > 10%	-7.2% Weak ↓ Weak Declining Free cash flow as a percentage of revenue Optimal: > 10%	33.8% Excellent ↓ Excellent Declining Free cash flow as a percentage of revenue Optimal: > 10%	44.0% Excellent ↑ Excellent Improving Free cash flow as a percentage of revenue Optimal: > 10%	31.8% Excellent ↓ Excellent Declining Free cash flow as a percentage of revenue Optimal: > 10%	48.2% Excellent ↑ Excellent Improving Free cash flow as a percentage of revenue Optimal: > 10%	35.9% Excellent ↑ Excellent Improving Free cash flow as a percentage of revenue Optimal: > 10%	38.5% Excellent ↑ Excellent Improving Free cash flow as a percentage of revenue Optimal: > 10%	30.0% Excellent ↑ Excellent Improving Free cash flow as a percentage of revenue Optimal: > 10%	10.5% Fair ↑ Fair Improving Free cash flow as a percentage of revenue Optimal: > 10%	-39.8% Weak ↓ Weak Declining Free cash flow as a percentage of revenue Optimal: > 10%	-97.2% Weak ↓ Weak Declining Free cash flow as a percentage of revenue Optimal: > 10%	-8.5% Weak ↓ Weak Declining Free cash flow as a percentage of revenue Optimal: > 10%	12.9% Fair ↑ Fair Improving Free cash flow as a percentage of revenue Optimal: > 10%	7.7% Caution ↑ Caution Improving Free cash flow as a percentage of revenue Optimal: > 10%	—	-442.7% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	-147.4% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—
FCF / Net Income (x)	0.81x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	1.48x Good ↑ Good Improving Free cash flow relative to reported net income Optimal: > 1x	0.92x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	1.18x Fair → Fair Stable Free cash flow relative to reported net income Optimal: > 1x	1.03x Fair ↑ Fair Improving Free cash flow relative to reported net income Optimal: > 1x	1.10x Fair ↓ Fair Declining Free cash flow relative to reported net income Optimal: > 1x	1.27x Good ↑ Good Improving Free cash flow relative to reported net income Optimal: > 1x	0.56x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	2.83x Excellent ↑ Excellent Improving Free cash flow relative to reported net income Optimal: > 1x	-1.60x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.74x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.76x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.23x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	-1.84x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	3.69x Excellent ↑ Excellent Improving Free cash flow relative to reported net income Optimal: > 1x	—	0.70x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	0.56x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—

🎯 Is capital allocation efficient? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗	FY 2009 Dec 31, 2009 10-K ↗	FY 2008 Dec 31, 2008 10-K ↗	FY 2007 Dec 31, 2007 10-K ↗
Return on Invested Capital (%)	19.0% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	3.1% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	18.0% Excellent ↓ Excellent Declining Return earned on debt + equity capital invested Optimal: > 10%	24.3% Excellent ↓ Excellent Declining Return earned on debt + equity capital invested Optimal: > 10%	23.6% Excellent Excellent Return earned on debt + equity capital invested Optimal: > 10%	28.6% Excellent Excellent Return earned on debt + equity capital invested Optimal: > 10%	—	—	4.8% Caution ↑ Caution Improving Return earned on debt + equity capital invested Optimal: > 10%	0.7% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-39.2% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-50.9% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-35.5% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	0.2% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	11.4% Good Good Return earned on debt + equity capital invested Optimal: > 10%	-109.1% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	—	—	—
Return on Capital (%) (%)	16.3% Excellent ↑ Excellent Improving Operating profit relative to total assets Optimal: > 10%	-1.0% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	16.9% Excellent ↓ Excellent Declining Operating profit relative to total assets Optimal: > 10%	23.7% Excellent ↑ Excellent Improving Operating profit relative to total assets Optimal: > 10%	20.7% Excellent ↑ Excellent Improving Operating profit relative to total assets Optimal: > 10%	24.3% Excellent ↑ Excellent Improving Operating profit relative to total assets Optimal: > 10%	14.4% Good ↑ Good Improving Operating profit relative to total assets Optimal: > 10%	10.2% Good ↑ Good Improving Operating profit relative to total assets Optimal: > 10%	3.5% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	0.3% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-18.7% Weak → Weak Stable Operating profit relative to total assets Optimal: > 10%	-29.7% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-26.3% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	0.1% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	5.2% Caution ↑ Caution Improving Operating profit relative to total assets Optimal: > 10%	-40.3% Weak Weak Operating profit relative to total assets Optimal: > 10%	-31.4% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—
Return on Common Equity (%) (%)	21.2% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+41%)	-3.3% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-122%)	20.6% Excellent ↓ Excellent Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+37%)	23.9% Excellent ↓ Excellent Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+59%)	23.2% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+55%)	31.2% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+108%)	—	—	13.0% Fair ↑ Fair Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-13%)	-9.7% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-165%)	-59.2% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-495%)	-68.7% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-558%)	-32.8% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-319%)	-10.7% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-171%)	3.8% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-75%)	-149.7% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1098%)	—	—	—

⚖️ Is the balance sheet risky? 2 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗	FY 2009 Dec 31, 2009 10-K ↗	FY 2008 Dec 31, 2008 10-K ↗	FY 2007 Dec 31, 2007 10-K ↗
Interest Coverage (x)	336.56x Excellent ↑ Excellent Improving Operating income divided by interest expense Optimal: > 5x	-7.64x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	88.91x Excellent ↑ Excellent Improving Operating income divided by interest expense Optimal: > 5x	82.36x Excellent ↑ Excellent Improving Operating income divided by interest expense Optimal: > 5x	49.42x Excellent ↑ Excellent Improving Operating income divided by interest expense Optimal: > 5x	52.41x Excellent ↑ Excellent Improving Operating income divided by interest expense Optimal: > 5x	20.47x Excellent ↑ Excellent Improving Operating income divided by interest expense Optimal: > 5x	8.76x Good Good Operating income divided by interest expense Optimal: > 5x	1.79x Caution Caution Operating income divided by interest expense Optimal: > 5x	—	—	—	—	0.14x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	2.96x Caution ↑ Caution Improving Operating income divided by interest expense Optimal: > 5x	-36.11x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-46.54x Weak Weak Operating income divided by interest expense Optimal: > 5x	-34.35x Weak Weak Operating income divided by interest expense Optimal: > 5x	—
Net Debt (USD)	$-5.08B	$-4.57B	$-10.37B	$-10.50B	$-6.79B	$-5.99B	$-3.11B	$-2.65B	$-1.67B	$-1.18B	$-714.77M	$-625.26M	$-569.30M	$-489.41M	$-475.32M	$-243.20M	$-446.66M	$-389.12M	$-355.66M

📊 What does each share earn? 6 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗	FY 2009 Dec 31, 2009 10-K ↗	FY 2008 Dec 31, 2008 10-K ↗	FY 2007 Dec 31, 2007 10-K ↗
Revenue per Share (USD)	$46.94	$42.73	$38.30	$34.87	$29.39	$23.89	$16.21	$11.98	$10.00	$6.96	$4.28	$2.47	$5.39	$7.20	$6.88	$0.72	$0.59	$1.25	—
Basic EPS, GAAP (USD)	$15.46	$-2.08	$14.05	$12.97	$9.09	$10.44	$4.58	$8.24	$1.06	$-0.46	$-2.31	$-3.14	$-1.98	$-0.50	$0.14	$-3.77	$-3.71	$-3.27	—
Free Cash Flow per Share (USD)	$12.49	$-3.06	$12.95	$15.33	$9.35	$11.52	$5.82	$4.62	$3.00	$0.73	$-1.70	$-2.40	$-0.46	$0.93	$0.53	—	$-2.60	$-1.84	—
Book Value per Share (USD)	$73.49	$63.87	$68.22	$54.13	$39.69	$33.42	—	—	$8.01	$4.66	$3.82	$4.45	$5.80	$4.60	$3.76	$2.48	—	—	—
Tangible Book Value per Share (USD)	$67.54	$56.42	$60.74	$47.55	$34.18	$28.03	—	—	$7.81	$4.46	$3.61	$4.28	$5.67	$4.46	$3.61	$2.35	—	—	—
Basic Weighted Avg Shares (shares)	255.70M	257.90M	257.70M	256.10M	257.70M	259.80M	256.73M	254.29M	248.86M	244.69M	241.31M	235.31M	224.91M	211.95M	204.89M	200.40M	173.26M	140.56M	—

🏦 How resilient is the balance sheet? 2 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗	FY 2009 Dec 31, 2009 10-K ↗	FY 2008 Dec 31, 2008 10-K ↗	FY 2007 Dec 31, 2007 10-K ↗
Working Capital (USD)	$7.34B	$6.03B	$10.60B	$10.49B	$7.42B	$6.26B	$3.49B	$2.72B	$1.84B	$1.04B	$900.99M	$1.18B	$1.19B	$1.16B	$938.91M	$582.26M	$1.02B	—	—
Total Equity (USD)	$18.67B	$16.41B	$17.58B	$13.91B	$10.10B	$8.69B	—	—	$2.03B	$1.16B	$939.97M	$1.08B	$1.36B	$999.18M	$786.84M	$503.97M	—	—	—

📋 What is driving earnings? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗	FY 2009 Dec 31, 2009 10-K ↗	FY 2008 Dec 31, 2008 10-K ↗	FY 2007 Dec 31, 2007 10-K ↗
Sales/Revenue/Turnover (USD)	$12.00B	$11.02B	$9.87B	$8.93B	$7.57B	$6.21B	$4.16B	$3.05B	$2.49B	$1.70B	$1.03B	$580.41M	$1.21B	$1.53B	$1.41B	$143.37M	$101.89M	$175.50M	—
Depreciation Expense (USD)	$209.80M	$207.20M	$181.30M	$148.30M	$125.60M	$109.50M	$106.94M	$72.42M	$61.40M	$61.40M	$62.34M	$63.26M	$48.37M	$38.19M	$35.04M	$30.46M	$30.11M	$32.20M	—
Net Income, GAAP (USD)	$3.95B	$-535.60M	$3.62B	$3.32B	$2.34B	$2.71B	$1.18B	$2.10B	$263.48M	$-112.05M	$-556.33M	$-738.55M	$-445.03M	$-107.03M	$29.57M	$-754.63M	$-642.18M	$-459.85M	—
Operating Cash Flow (USD)	$3.63B	$-492.60M	$3.54B	$4.13B	$2.64B	$3.25B	$1.57B	$1.27B	$844.94M	$236.10M	$-365.43M	$-513.20M	$-51.57M	$267.84M	$143.74M	—	$-427.59M	$-226.48M	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 19 years · 71 quarters

VERTEX PHARMACEUTICALS INC / MA

Analytical Summary

19-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare VRTX with peers